Ayala Pharmaceuticals Inc (OTCPK:ADXS)
$ 0.027 0 (0%) Market Cap: 1.15 Mil Enterprise Value: 4.58 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 0/100

Advaxis Inc Extraordinary Shareholders Meeting Transcript

Dec 07, 2021 / 03:00PM GMT
Release Date Price: $9.57 (+1.81%)
Operator

Good day, and welcome to the Advaxis, Inc. 2021 Special Meeting. I would now like to turn the conference over to Ken Berlin. Please go ahead.

Kenneth A. Berlin
Advaxis, Inc. - President, Interim CFO, CEO & Director

Good morning. I'm Kenneth Berlin, Chief Executive Officer of Advaxis, Inc. welcome, and thank you for joining us for the reconvened special meeting of stockholders. As the company has reported previously in its filings with the Securities and Exchange Commission at our Special Meeting of Stockholders held on November 16, 2021, the adjournment proposal submitted to stockholders for vote at our special meeting was approved. As authorized by that proposal, the Special Meeting of Stockholders was partially adjourned in order to solicit additional proxies to vote in favor of proposals 1, 2, 3 and 4.

Accordingly, the polls with respect only to proposals 1, 2, 3 and 4 remained open following our Special Meeting of Stockholders held on November 16, 2021. Notice of the special meeting was filed with the SEC and distributed to stockholders of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot